Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1995-06-06
1999-03-02
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424426, A61K 916, A61K 4734
Patent
active
058767614
ABSTRACT:
The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
REFERENCES:
patent: 4479911 (1984-10-01), Fong
patent: 4637905 (1987-01-01), Gardner
patent: 4650787 (1987-03-01), Schally et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4759577 (1988-07-01), Schally et al.
patent: 4767628 (1988-08-01), Hutchinson
patent: 4853226 (1989-08-01), Machida et al.
patent: 4859763 (1989-08-01), Takayanagi et al.
patent: 4863736 (1989-09-01), Azain et al.
Mason-Garcia, Proc. National Acad. Science, vol. 85, pp. 5688-5692 (1988).
Maulding, Journal of Controlled release, vol. 6, pp. 167-176 (1987).
Bodmer David
Fong Jones W.
Kissel Thomas
Maulding Hawkins V.
Nagele Oskar
Novartis AG
Pfeiffer Hesna J.
Webman Edward J.
LandOfFree
Sustained release formulations of water soluble peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release formulations of water soluble peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulations of water soluble peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-420083